 | • レポートコード：QYR9N7924 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、放射線免疫療法のグローバル市場について調査・分析したレポートで、種類別（非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、その他）、用途別（腫瘍抗原、放射性核種、抗体）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・放射線免疫療法の世界市場規模 ・主要企業別市場シェア ・放射線免疫療法の世界市場規模：種類別（非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、その他） ・放射線免疫療法の世界市場規模：用途別（腫瘍抗原、放射性核種、抗体） ・放射線免疫療法のアメリカ市場規模（種類別、用途別） ・放射線免疫療法のヨーロッパ市場規模（種類別、用途別） ・放射線免疫療法の中国市場規模（種類別、用途別） ・放射線免疫療法の日本市場規模（種類別、用途別） ・放射線免疫療法の東南アジア市場規模（種類別、用途別） ・放射線免疫療法のインド市場規模（種類別、用途別） ・放射線免疫療法の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・放射線免疫療法の世界市場予測（2019年-2025年） ・放射線免疫療法の地域別市場予測（2019年-2025年） ... |
In 2018, the global Radioimmunotherapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Radioimmunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Radioimmunotherapy development in United States, Europe and China.
The key players covered in this study
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
Market segment by Type, the product can be split into
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
Market segment by Application, split into
Tumor Antigens
Radionuclides
Antibodies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Radioimmunotherapy status, future forecast, growth opportunity, key market and key players.
To present the Radioimmunotherapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Radioimmunotherapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Radioimmunotherapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Non Hodgkin Lymphoma (NHL)
1.4.3 Follicular Lymphoma
1.4.4 Solid Tumors
1.4.5 Breast Cancer
1.4.6 Ovarian Cancer
1.4.7 Osteosarcoma
1.4.8 Neuroblastoma
1.4.9 Prostate Cancer
1.5 Market by Application
1.5.1 Global Radioimmunotherapy Market Share by Application (2014-2025)
1.5.2 Tumor Antigens
1.5.3 Radionuclides
1.5.4 Antibodies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Radioimmunotherapy Market Size
2.2 Radioimmunotherapy Growth Trends by Regions
2.2.1 Radioimmunotherapy Market Size by Regions (2014-2025)
2.2.2 Radioimmunotherapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Radioimmunotherapy Market Size by Manufacturers
3.1.1 Global Radioimmunotherapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Radioimmunotherapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 Radioimmunotherapy Key Players Head office and Area Served
3.3 Key Players Radioimmunotherapy Product/Solution/Service
3.4 Date of Enter into Radioimmunotherapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Radioimmunotherapy Market Size by Type (2014-2019)
4.2 Global Radioimmunotherapy Market Size by Application (2014-2019)
5 United States
5.1 United States Radioimmunotherapy Market Size (2014-2019)
5.2 Radioimmunotherapy Key Players in United States
5.3 United States Radioimmunotherapy Market Size by Type
5.4 United States Radioimmunotherapy Market Size by Application
6 Europe
6.1 Europe Radioimmunotherapy Market Size (2014-2019)
6.2 Radioimmunotherapy Key Players in Europe
6.3 Europe Radioimmunotherapy Market Size by Type
6.4 Europe Radioimmunotherapy Market Size by Application
7 China
7.1 China Radioimmunotherapy Market Size (2014-2019)
7.2 Radioimmunotherapy Key Players in China
7.3 China Radioimmunotherapy Market Size by Type
7.4 China Radioimmunotherapy Market Size by Application
8 Japan
8.1 Japan Radioimmunotherapy Market Size (2014-2019)
8.2 Radioimmunotherapy Key Players in Japan
8.3 Japan Radioimmunotherapy Market Size by Type
8.4 Japan Radioimmunotherapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Radioimmunotherapy Market Size (2014-2019)
9.2 Radioimmunotherapy Key Players in Southeast Asia
9.3 Southeast Asia Radioimmunotherapy Market Size by Type
9.4 Southeast Asia Radioimmunotherapy Market Size by Application
10 India
10.1 India Radioimmunotherapy Market Size (2014-2019)
10.2 Radioimmunotherapy Key Players in India
10.3 India Radioimmunotherapy Market Size by Type
10.4 India Radioimmunotherapy Market Size by Application
11 Central & South America
11.1 Central & South America Radioimmunotherapy Market Size (2014-2019)
11.2 Radioimmunotherapy Key Players in Central & South America
11.3 Central & South America Radioimmunotherapy Market Size by Type
11.4 Central & South America Radioimmunotherapy Market Size by Application
12 International Players Profiles
12.1 Bayer Healthcare Pharmaceuticals
12.1.1 Bayer Healthcare Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Radioimmunotherapy Introduction
12.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2014-2019)
12.1.5 Bayer Healthcare Pharmaceuticals Recent Development
12.2 BioSynthema
12.2.1 BioSynthema Company Details
12.2.2 Company Description and Business Overview
12.2.3 Radioimmunotherapy Introduction
12.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2014-2019)
12.2.5 BioSynthema Recent Development
12.3 Clarity Pharmaceuticals
12.3.1 Clarity Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Radioimmunotherapy Introduction
12.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2014-2019)
12.3.5 Clarity Pharmaceuticals Recent Development
12.4 Curasight
12.4.1 Curasight Company Details
12.4.2 Company Description and Business Overview
12.4.3 Radioimmunotherapy Introduction
12.4.4 Curasight Revenue in Radioimmunotherapy Business (2014-2019)
12.4.5 Curasight Recent Development
12.5 Endocyte
12.5.1 Endocyte Company Details
12.5.2 Company Description and Business Overview
12.5.3 Radioimmunotherapy Introduction
12.5.4 Endocyte Revenue in Radioimmunotherapy Business (2014-2019)
12.5.5 Endocyte Recent Development
12.6 Immunomedics
12.6.1 Immunomedics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Radioimmunotherapy Introduction
12.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2014-2019)
12.6.5 Immunomedics Recent Development
12.7 Molecular Insight Pharmaceuticals
12.7.1 Molecular Insight Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Radioimmunotherapy Introduction
12.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2014-2019)
12.7.5 Molecular Insight Pharmaceuticals Recent Development
12.8 Nordic Nanovector
12.8.1 Nordic Nanovector Company Details
12.8.2 Company Description and Business Overview
12.8.3 Radioimmunotherapy Introduction
12.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2014-2019)
12.8.5 Nordic Nanovector Recent Development
12.9 PDL Biopharma
12.9.1 PDL Biopharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Radioimmunotherapy Introduction
12.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2014-2019)
12.9.5 PDL Biopharma Recent Development
12.10 Philogen
12.10.1 Philogen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Radioimmunotherapy Introduction
12.10.4 Philogen Revenue in Radioimmunotherapy Business (2014-2019)
12.10.5 Philogen Recent Development
12.11 RadioMedix
12.12 Stella Pharma
12.13 Telix Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Radioimmunotherapy Key Market Segments
Table Key Players Radioimmunotherapy Covered
Table Global Radioimmunotherapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Radioimmunotherapy Market Size Market Share by Type 2014-2025
Figure Non Hodgkin Lymphoma (NHL) Figures
Table Key Players of Non Hodgkin Lymphoma (NHL)
Figure Follicular Lymphoma Figures
Table Key Players of Follicular Lymphoma
Figure Solid Tumors Figures
Table Key Players of Solid Tumors
Figure Breast Cancer Figures
Table Key Players of Breast Cancer
Figure Ovarian Cancer Figures
Table Key Players of Ovarian Cancer
Figure Osteosarcoma Figures
Table Key Players of Osteosarcoma
Figure Neuroblastoma Figures
Table Key Players of Neuroblastoma
Figure Prostate Cancer Figures
Table Key Players of Prostate Cancer
Table Global Radioimmunotherapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Tumor Antigens Case Studies
Figure Radionuclides Case Studies
Figure Antibodies Case Studies
Figure Radioimmunotherapy Report Years Considered
Table Global Radioimmunotherapy Market Size 2014-2025 (Million US$)
Figure Global Radioimmunotherapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Radioimmunotherapy Market Size by Regions 2014-2025 (Million US$)
Table Global Radioimmunotherapy Market Size by Regions 2014-2019 (Million US$)
Table Global Radioimmunotherapy Market Share by Regions 2014-2019
Figure Global Radioimmunotherapy Market Share by Regions 2014-2019
Figure Global Radioimmunotherapy Market Share by Regions 2019
Table Market Top Trends
Table Global Radioimmunotherapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Radioimmunotherapy Market Share by Manufacturers (2014-2019)
Figure Global Radioimmunotherapy Market Share by Manufacturers in 2018
Table Global Radioimmunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Radioimmunotherapy Product/Solution/Service
Table Date of Enter into Radioimmunotherapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table Global Radioimmunotherapy Market Size Share by Type (2014-2019)
Figure Global Radioimmunotherapy Market Size Market Share by Type (2014-2019)
Table Global Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table Global Radioimmunotherapy Market Size Share by Application (2014-2019)
Figure Global Radioimmunotherapy Market Size Market Share by Application (2014-2019)
Figure Global Radioimmunotherapy Revenue Market Share by Application in 2018
Figure United States Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table United States Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table United States Key Players Radioimmunotherapy Market Share (2018-2019)
Table United States Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table United States Radioimmunotherapy Market Share by Type (2014-2019)
Table United States Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table United States Radioimmunotherapy Market Share by Application (2014-2019)
Figure Europe Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Radioimmunotherapy Market Share (2018-2019)
Table Europe Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table Europe Radioimmunotherapy Market Share by Type (2014-2019)
Table Europe Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table Europe Radioimmunotherapy Market Share by Application (2014-2019)
Figure China Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table China Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table China Key Players Radioimmunotherapy Market Share (2018-2019)
Table China Radioimmunotherapy Market Size by Type (2014-20189) (Million US$)
Table China Radioimmunotherapy Market Share by Type (2014-2019)
Table China Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table China Radioimmunotherapy Market Share by Application (2014-2019)
Figure Japan Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Radioimmunotherapy Market Share (2018-2019)
Table Japan Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table Japan Radioimmunotherapy Market Share by Type (2014-2019)
Table Japan Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table Japan Radioimmunotherapy Market Share by Application (2014-2019)
Figure Southeast Asia Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Radioimmunotherapy Market Share (2018-2019)
Table Southeast Asia Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Radioimmunotherapy Market Share by Type (2014-2019)
Table Southeast Asia Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Radioimmunotherapy Market Share by Application (2014-2019)
Figure India Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table India Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table India Key Players Radioimmunotherapy Market Share (2018-2019)
Table India Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table India Radioimmunotherapy Market Share by Type (2014-2019)
Table India Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table India Radioimmunotherapy Market Share by Application (2014-2019)
Figure Central & South America Radioimmunotherapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Radioimmunotherapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Radioimmunotherapy Market Share (2018-2019)
Table Central & South America Radioimmunotherapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Radioimmunotherapy Market Share by Type (2014-2019)
Table Central & South America Radioimmunotherapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Radioimmunotherapy Market Share by Application (2014-2019)
Table Bayer Healthcare Pharmaceuticals Company Details
Table Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2014-2019) (Million US$)
Figure Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Bayer Healthcare Pharmaceuticals Recent Development
Table BioSynthema Company Details
Table BioSynthema Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure BioSynthema Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table BioSynthema Recent Development
Table Clarity Pharmaceuticals Company Details
Table Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Clarity Pharmaceuticals Recent Development
Table Curasight Company Details
Table Curasight Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Curasight Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Curasight Recent Development
Table Endocyte Company Details
Table Endocyte Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Endocyte Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Endocyte Recent Development
Table Immunomedics Company Details
Table Immunomedics Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Immunomedics Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Immunomedics Recent Development
Table Molecular Insight Pharmaceuticals Company Details
Table Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Molecular Insight Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Molecular Insight Pharmaceuticals Recent Development
Table Nordic Nanovector Company Details
Table Nordic Nanovector Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Nordic Nanovector Recent Development
Table PDL Biopharma Company Details
Table PDL Biopharma Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure PDL Biopharma Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table PDL Biopharma Recent Development
Table Philogen Company Details
Table Philogen Revenue in Radioimmunotherapy Business (2014-2019)(Million US$)
Figure Philogen Revenue Growth Rate in Radioimmunotherapy Business (2014-2019)
Table Philogen Recent Development
Table RadioMedix Company Details
Table Stella Pharma Company Details
Table Telix Pharmaceuticals Company Details
Table Global Radioimmunotherapy Market Size by Regions (Million US$) 2019-2025
Figure Global Radioimmunotherapy Market Size Share by Regions (2019-2025)
Figure Global Radioimmunotherapy Market Size Share by Regions in 2025
Figure United States Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure China Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure India Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Radioimmunotherapy Market Size Forecast (2019-2025)(Million USD)
Table Global Radioimmunotherapy Market Size by Product (2019-2025) (Million US$)
Figure Global Radioimmunotherapy Market Size by Product (2019-2025)
Figure Global Radioimmunotherapy Market Size by Product in 2025
Table Global Radioimmunotherapy Market Size by Application (2019-2025) (Million US$)
Figure Global Radioimmunotherapy Market Size by Application (2019-2025)
Figure Global Radioimmunotherapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の濾胞性リンパ腫市場：市場規模・現状・予測 Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…- 世界の前立腺がんバイオマーカー市場：市場規模・現状・予測 Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. In 2018, the global Prostate Cancer Biomarker market size was xx million US$ …
- 世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 世界の前立腺がんのスクリーニング市場：市場規模・現状・予測 Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measur…
- 世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測 In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study …